透過您的圖書館登入
IP:34.206.1.144
  • 學位論文

結合感染症專家及微生物報告的早期介入 抗菌藥物管理方案對菌血症病人處理影響之研究

Impact of an Antimicrobial Stewardship Program by Linking Early Intervention of Infectious Disease Specialists and Microbiologic Reports on Management of Bacteremic Patients

指導教授 : 李金德
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


研究背景與目的﹕不適當及過度的抗生素使用與其導致相關的細菌抗藥性病菌的出現是目前一項重大的公共衛生問題。菌血症是一種嚴重的感染症,其導致可觀的罹病率,死亡率和醫療費用支出。而細菌抗藥性的問題進一步減少治療感染症藥物的選擇性並降低病人的安全。本研究為回溯評估一項結合感染症醫師及微生物報告的早期介入菌血症病人處理的抗菌藥物管理方案的介入措施前期、後期的差異。 研究樣本與方法﹕南部一家1,400張病床的醫療中心及2011年377名選定重要致病/抗藥性菌菌血症病人。回溯收集醫院住院病人行政管理資料、藥局藥物使用量及費用、及選定重要致病/抗藥性菌菌血症病人病歷資料。 結果﹕在實施結合感染病專家及微生物實驗室血液培養陽性報告介入前期(2011年1至6月)及介入後期(2011年7月至12月),該醫院內住院病人重要醫療指標並無差異。在介入後期,靜脈注射及口服抗菌藥物的總使用量減少217.8 DDD/1,000 住院病人日(PD) (11.7%),其中以penicillins、cephalosporins、及quinolones減幅都 >10%﹔全院抗菌藥費、住院抗菌藥費、及平均每住院人日抗菌藥費分別減少7,070,288元(9.0%)、5,991,896元(12.2%)、及40.5元/PD (14.0%)。重要院內感染抗藥性細菌carbapenem-resistant (CR) Acinetobacter baumannii及CR-Pseudomonas aeruginosa抗藥性比率在各屬菌種內呈現下降,分別為50% vs. 43% (p < 0.05)及8.9% vs. 6.0% (p < 0.05)。Etended-spectrum β-lactamase Escherichia coli及vancomycin-resistant Enterococcus faecium抗藥性比率則上升,分別為16.6% vs. 19.2% (p < 0.05)及14.0% vs. 30.7% (p < 0.05)。分析377位重要致病菌菌血症病人,介入前期病人較年長 (72.3 ± 15. vs. 68.8 ± 16.2, p = 0.031),慢性心臟衰竭較多(10.6% vs. 4.1%, p = 0.018),長期卧床較多(25.1% vs. 13.5%, p = 0.005);然而,菌血症嚴重度中,McCabe-Jackon分類則以介入後期終將致命及致命分類較多(p = 0.003) , 表現急性血液衰竭及肝衰竭的比率亦以後期為高。介入前、後期377位菌血症病人醫療成效的比較:適當抗菌藥物使用延遲時間、適當抗菌藥物被使用時機、及死亡率無差異。 結論﹕本研究強調抗菌藥物管理方案的重要,藉由結合感染症專家及微生物報告的早期主動介入菌血症病人的抗菌藥物管理措施,可有效降低醫院內抗菌藥物的使用量及費用。

並列摘要


Background & Purposes. Inappropriate and over use of antimicrobial agents and its’ related emergence of antimicrobial resistance are major public issues concerned currently. Bacteremia is a severe infection and leads into considerable morbidity, mortality, and medical costs. The emergence of antimicrobial resistance embarrasses the selection in treatment of infectious diseases and injures patient safety. The study was targeted to retrospectively review the impact of an antimicrobial stewardship program by linking early intervention of infectious disease specialists and microbiologic reports on management of bacteremic patients. Materials & Methods. A 1,400-bed medical center in southern Taiwan and 377 targeted bacteremic patients with important or drug-resistant pathogens. To collect administrative data of hospitalized patients, pharmacy prescription and expenditure, and clinical relevant information, by chart review, in targeted bacteremic patients caused by important or multidrug-resistant pathogens respectively. Results. Between the pre- and post-intervention phases (January 1, 2011 – June 30,2011 vs. July 1, 2011 – December 31, 2011), there was no difference in administrative indicators. In the post-phase, the amounts in usage of intravenous and oral antimicrobial agents decreased by 217.8 DDD/1,000 inpatients-day (PD) (11.7%); the reduction occurred most in penicillins, cephalosporins, and quinolones (>10%). The expenditure of all antimicrobials, antimicrobials for inpatients, and average daily cost of inpatient-day decreased in post-phase: NT$ 7,070,288(9.0%), NT$5,991,896 (12.2%), and NT$ 40.5/PD (14.0%), respectively. The carbapenem-resistant rate in Acinetobacter baumannii and Pseudomonas aeruginosa decreased from 50% to 43% and 8.9% to 6.0%, respectively (p < 0.05). The percentage of extended-spectrum β-lactamase producing Escherichia coli and vancomycin-resistant Enterococcus faecium increased from 16.6% to 19.2% and from 14.0% to 30.7%, respectively, (p < 0.05). In an analysis of 377 bacteremic patients caused by important pathogens, patients in pre-phase were with older age (72.3 ± 15. vs. 68.8 ± 16.2, p = 0.031), more cases with chronic heart failure (10.6% vs. 4.1%, p = 0.018) and in bed-ridden (25.1% vs. 13.5%, p = 0.005).However, cases in post-phase with higher severity of infection by McCabe-Jackson category (p = 0003), and more cases presenting acute hematologic failure and acute liver failure. In comparison between two phases, there was no difference in delay time between bacteremia onset and use of appropriate antimicrobials, timing of appropriate antimicrobials used, and mortality rate. Conclusion. This study underlines the importance of antimicrobial stewardship program. By linking early intervention of infectious disease specialists and microbiologic reports on management of bacteremic patients can effectively reduce the expenditure of antimicrobial expenditure in hospital.

參考文獻


1. Anderson RN, Smith BL: Deaths: leading causes for 2002. Natl Vital Stat Rep 2005, 53(17):1-89.
2. Wenzel RP, Edmond MB: The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 2001, 7(2):174-177.
3. Cortes JA, Garzon DC, Navarrete JA, Contreras KM: Impact of inappropriate antimicrobial therapy on patients with bacteremia in intensive care units and resistance patterns in Latin America. Rev Argent Microbiol 2010, 42(3):230-234.
4. Cosgrove SE: The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006, 42 Suppl 2:S82-89.
5. Dellit TH, Owens RC, McGowan JE, Jr., Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF et al: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44(2):159-177.

延伸閱讀